Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

被引：0
|
作者：
Prooksa Ananchuensook
Supachaya Sriphoosanaphan
Sirinporn Suksawatamnauy
Nipaporn Siripon
Nutcha Pinjaroen
Nopavut Geratikornsupuk
Stephen J. Kerr
Kessarin Thanapirom
Piyawat Komolmit
机构：
[1] Chulalongkorn University,Division of Gastroenterology, Department of Medicine, Faculty of Medicine
[2] King Chulalongkorn Memorial Hospital,Center of Excellence in Liver Diseases
[3] Thai Red Cross Society,Liver Fibrosis and Cirrhosis Research Unit
[4] Chulalongkorn University,Department of Radiology, Faculty of Medicine
[5] Chulalongkorn University,Department of Medicine
[6] Queen Savang Vadhana Memorial Hospital,Center of Excellence in Biostatistics, Faculty of Medicine
[7] Chulalongkorn University,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
Easy albumin-bilirubin score; Intermediate-stage hepatocellular carcinoma; Trans-arterial chemoembolization; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
    Ananchuensook, Prooksa
    Sriphoosanaphan, Supachaya
    Suksawatamnauy, Sirinporn
    Siripon, Nipaporn
    Pinjaroen, Nutcha
    Geratikornsupuk, Nopavut
    Kerr, Stephen J.
    Thanapirom, Kessarin
    Komolmit, Piyawat
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [2] Trans-arterial chemoembolization (tace) in patients with hepatocellular carcinoma
    Menon, Sreekanth
    Ramachandran, T. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 724 - 724
  • [3] Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma
    Nishikawa, Hiroki
    Osaki, Yukio
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Takeda, Haruhiko
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Nishiguchi, Shuhei
    ONCOLOGY REPORTS, 2014, 31 (01) : 65 - 72
  • [4] New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Lee, Han Chu
    Sung, Kyu-Bo
    Ko, Heung-Kyu
    Ko, Gi-young
    Gwon, Dong Il
    Kim, Jong Woo
    Lim, Yung-Suk
    Park, Seong Ho
    LIVER INTERNATIONAL, 2017, 37 (12) : 1861 - 1868
  • [5] Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Minami, Tomohiro
    Kono, Masashi
    Chishina, Hirokazu
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    LIVER CANCER, 2015, 4 (04) : 253 - 262
  • [6] Role of Trans-Arterial Chemoembolization (TACE) in patients with hepatocellular carcinoma
    Meshari, A. -A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (18) : 6764 - 6771
  • [7] Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
    Nishikawa, Hiroki
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Takeda, Haruhiko
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Osaki, Yukio
    JOURNAL OF CANCER, 2014, 5 (07): : 590 - 597
  • [8] Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
    Chi, Chen-Ta
    Lee, I-Cheng
    Lee, Rheun-Chuan
    Hung, Ya-Wen
    Su, Chien-Wei
    Hou, Ming-Chih
    Chao, Yee
    Huang, Yi-Hsiang
    CANCERS, 2021, 13 (17)
  • [9] Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate-stage hepatocellular carcinoma undergoing chemoembolization
    Bannangkoon, Kittipitch
    Hongsakul, Keerati
    Tubtawee, Teeravut
    CANCER IMAGING, 2023, 23 (01)
  • [10] Risk factors for 1-year mortality in patients with intermediate-stage hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization
    Lin, Chih-Lin
    Hsieh, Chia-Feng
    Chen, Tom
    Lin, Tsung-Jung
    Huang, Ting-Chang
    Lee, Hsi-Chang
    Chen, Kuan-Yang
    Liao, Li-Ying
    Wang, Chung-Kwe
    ADVANCES IN DIGESTIVE MEDICINE, 2014, 1 (04) : 126 - 131
12345